AP-2202

Primary objective: To evaluate the safety and tolerability of AP-2202 tablets after single and multiple oral administration in healthy Chinese participants; Secondary objective: To evaluate the pharmacodynamic (PD) characteristics of AP-2202 tablets after single and multiple oral administration in healthy Chinese participants; To evaluate the effects of different administration methods (1 hour before meals or with meals) on the pharmacodynamics of AP-2202 tablets in healthy Chinese participants;